Evaluation of Molecularly Imprinted Polymers as Synthetic Virus Neutralizing Antibody Mimics

Rapid development of antibody-based therapeutics are crucial to the agenda of innovative manufacturing of macromolecular therapies to combat emergent diseases. Although highly specific, antibody therapies are costly to produce. Molecularly imprinted polymers (MIPs) constitute a rapidly-evolving clas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Bioeng Biotechnol
Autors principals: Graham, Simon P., El-Sharif, Hazim F., Hussain, Sabha, Fruengel, Rieke, McLean, Rebecca K., Hawes, Philippa C., Sullivan, Mark V., Reddy, Subrayal M.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Bioengineering and Biotechnology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6542949/
https://ncbi.nlm.nih.gov/pubmed/31179277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2019.00115
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars